Summit Therapeutics Inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
Summit Therapeutics Inc. entered into a sublease agreement effective November 1, 2026, with Genius 24C Inc. for approximately 2,382 square feet of office space at 601 Brickell Key Drive, Suite 900, Miami, Florida. The term runs 12 months through October 31, 2027. Specific rental rates are redacted as confidential; sublease incorporates terms from the underlying master lease dated May 12, 2025. Summit receives access to building amenities, office furniture, and up to 6 unreserved parking spaces.
Why this rating
Routine real estate sublease for modest office footprint (~2,382 sq ft). No material financial terms disclosed. Immaterial relative to $2.5B market cap; standard corporate facility consolidation.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.